83 FR 6573 - Submission for OMB Review; Comment Request
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families Federal Register Volume 83, Issue 31 (February 14, 2018)
Administration for Children and Families
Federal Register Volume 83, Issue 31 (February 14, 2018)
| Page Range | 6573-6574 | |
| FR Document | 2018-03091 |
[Federal Register Volume 83, Number 31 (Wednesday, February 14, 2018)] [Notices] [Pages 6573-6574] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-03091] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Submission for OMB Review; Comment Request Title: Office of Refugee Resettlement Cash and Medical Assistance Program Quarterly Report on Expenditures and Obligations. OMB No.: 0970-0407. Description: The Office of Refugee Resettlement (ORR) reimburses, to the extent of available appropriations, certain non-federal costs for the provision of cash and medical assistance to refugees and other eligible persons, along with allowable expenses for the administration of the refugee resettlement program at the State level. States, Wilson/ Fish projects (alternative projects for the administration of the refugee resettlement program), and State Replacement Designees currently submit the ORR-2 Financial Status Report in accordance with 45 CFR part 92 and 45 CFR part 74. This proposed data collection would collect financial status data (i.e., amounts of expenditures and obligations) broken down by the four program components: Refugee cash assistance, refugee medical assistance, health screening, and services for unaccompanied refugee minors as well as by program administration. This breakdown of financial status data on expenditures and obligations allows ORR to track program expenditures in greater detail to anticipate any funding issues and to meet the requirements of ORR regulations at 45 CFR 400.211 to collect these data for use in estimating annual costs of the refugee resettlement program. ORR must implement the methodology at 45 CFR 400.211 each year after receipt of its annual appropriation to ensure that the appropriated funds will be adequate for assistance to entering refugees. The estimating methodology prescribed in the ORR regulations requires the use of actual past costs by program component. In the event that the methodology indicates that appropriated funds are inadequate, ORR must take steps to reduce federal expenses, such as by limiting the number of months of eligibility for Refugee Cash Assistance and Refugee Medical Assistance. This proposed single-page report on expenditures and obligations will allow ORR to collect the necessary data to ensure that funds are adequate for the projected need and thereby meet the requirements of both the Refugee Act and ORR regulations. Respondents: State Agencies, the District of Columbia, Replacement Designees under 45 CFR 400.301(c), and Wilson-Fish Grantees (State 2 Agencies) administering or supervising the administration of programs under Title IV of the Act. Annual Burden Estimates ---------------------------------------------------------------------------------------------------------------- Number of Average burden Instrument Number of responses per hours per Total burden respondents respondent response hours ---------------------------------------------------------------------------------------------------------------- ORR Financial Status Report Cash and Medical 57 4 1.50 342 Assistance Program, Quarterly Report on Expenditures and Obligations............... ---------------------------------------------------------------------------------------------------------------- Estimated Total Annual Burden Hours: 342. Copies of the proposed collection may be obtained by writing to the Administration for Children and Families, Office of Planning, Research and Evaluation, 330 C Street SW, Washington, DC 20201. Attention Reports Clearance Officer. All requests should be identified by the title of the information collection. Email address: infocollection@acf.hhs.gov. OMB Comment: OMB is required to make a decision concerning the collection of information between 30 and 60 days after publication of this document in the Federal Register. Therefore, a comment is best assured of having its full effect if OMB receives it within 30 days of publication. Written comments and recommendations for the proposed information collection should be sent directly to the following: Office of Management and Budget, Paperwork Reduction Project, Email: OIRA_SUBMISSION@OMB.EOP.GOV, Attn: [[Page 6574]] Desk Officer for the Administration for Children and Families. Robert Sargis, Reports Clearance Officer. [FR Doc. 2018-03091 Filed 2-13-18; 8:45 am] BILLING CODE 4184-45-P
![Federal Register / Vol. 83, No. 31 / Wednesday, February 14, 2018 / Notices 6573
BILLING CODE 4163–19–C published on the NIOSH website and Refugee cash assistance, refugee medical
X. Drugs Removed From the NIOSH announced in a Federal Register notice. assistance, health screening, and
List of Hazardous Drugs Dated: February 8, 2018. services for unaccompanied refugee
John Howard, minors as well as by program
In a petition to NIOSH in February administration. This breakdown of
2017, the pharmaceutical company Director, National Institute for Occupational
Safety and Health, Centers for Disease Control financial status data on expenditures
Theravance Biopharma requested the and Prevention. and obligations allows ORR to track
removal of the drug telavancin from the program expenditures in greater detail
[FR Doc. 2018–02957 Filed 2–13–18; 8:45 am]
NIOSH List of Antineoplastic and Other to anticipate any funding issues and to
BILLING CODE 4163–19–P
Hazardous Drugs in Healthcare meet the requirements of ORR
Settings.22 The petition included an regulations at 45 CFR 400.211 to collect
analysis of animal developmental DEPARTMENT OF HEALTH AND these data for use in estimating annual
toxicity studies and argued that HUMAN SERVICES costs of the refugee resettlement
‘‘[p]lacing telavancin in the NIOSH program. ORR must implement the
category of a hazardous drug greatly Administration for Children and methodology at 45 CFR 400.211 each
overstates the occupational risk to Families year after receipt of its annual
healthcare workers handling
Submission for OMB Review; appropriation to ensure that the
telavancin.’’ In response, NIOSH
Comment Request appropriated funds will be adequate for
evaluated the information provided in
assistance to entering refugees. The
the petition as well as other sources Title: Office of Refugee Resettlement
provided to NIOSH by the manufacturer estimating methodology prescribed in
Cash and Medical Assistance Program the ORR regulations requires the use of
and determined that telavancin does not Quarterly Report on Expenditures and
meet the NIOSH definition of a actual past costs by program
Obligations. component. In the event that the
hazardous drug. NIOSH informed users OMB No.: 0970–0407.
of the 2016 List of this determination methodology indicates that
Description: The Office of Refugee appropriated funds are inadequate, ORR
via a web posting and responded to Resettlement (ORR) reimburses, to the
Theravance Biopharma with a letter must take steps to reduce federal
extent of available appropriations, expenses, such as by limiting the
dated April 12, 2017.23 Accordingly, certain non-federal costs for the
telavancin does not appear in the 2018 number of months of eligibility for
provision of cash and medical Refugee Cash Assistance and Refugee
update to the NIOSH List of assistance to refugees and other eligible
Antineoplastic and Other Hazardous Medical Assistance. This proposed
persons, along with allowable expenses
Drugs in Healthcare Settings. This single-page report on expenditures and
for the administration of the refugee
decision is considered final. obligations will allow ORR to collect the
resettlement program at the State level.
necessary data to ensure that funds are
XI. Final List of Drugs Proposed for States, Wilson/Fish projects (alternative
adequate for the projected need and
Placement on the NIOSH List of projects for the administration of the
refugee resettlement program), and State thereby meet the requirements of both
Hazardous Drugs the Refugee Act and ORR regulations.
Replacement Designees currently
After consideration of all public submit the ORR–2 Financial Status Respondents: State Agencies, the
comments received in the docket for Report in accordance with 45 CFR part District of Columbia, Replacement
this action, NIOSH will develop a final 92 and 45 CFR part 74. This proposed Designees under 45 CFR 400.301(c), and
list of drugs to be placed on the NIOSH data collection would collect financial Wilson-Fish Grantees (State 2 Agencies)
List of Antineoplastic and Other status data (i.e., amounts of administering or supervising the
Hazardous Drugs in Healthcare Settings, expenditures and obligations) broken administration of programs under Title
2018. The 2018 Update will be down by the four program components: IV of the Act.
ANNUAL BURDEN ESTIMATES
Number of Average
Number of responses Total burden
Instrument burden hours
respondents per hours
per response
respondent
ORR Financial Status Report Cash and Medical Assistance Program, Quar-
terly Report on Expenditures and Obligations ............................................. 57 4 1.50 342
Estimated Total Annual Burden should be identified by the title of the having its full effect if OMB receives it
Hours: 342. information collection. Email address: within 30 days of publication. Written
Copies of the proposed collection may infocollection@acf.hhs.gov. comments and recommendations for the
be obtained by writing to the OMB Comment: OMB is required to proposed information collection should
Administration for Children and make a decision concerning the be sent directly to the following: Office
Families, Office of Planning, Research collection of information between 30 of Management and Budget, Paperwork
daltland on DSKBBV9HB2PROD with NOTICES
and Evaluation, 330 C Street SW, and 60 days after publication of this Reduction Project, Email: OIRA_
Washington, DC 20201. Attention document in the Federal Register. SUBMISSION@OMB.EOP.GOV, Attn:
Reports Clearance Officer. All requests Therefore, a comment is best assured of
22 Harstad EB and Coleman R. Petition of and Other Hazardous Drugs in Healthcare Settings. 23 NIOSH letter to Eric Harstad and Rebecca
Theravance Biopharma US, Inc. to Remove February 28, 2017. Coleman. April 12, 2017.
Telavancin from the NIOSH List of Antineoplastic
VerDate Sep<11>2014 22:07 Feb 13, 2018 Jkt 244001 PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 E:\FR\FM\14FEN1.SGM 14FEN1](https://thefederalregister.org/doc/83_FR_6604/page/1.svg)
![6574 Federal Register / Vol. 83, No. 31 / Wednesday, February 14, 2018 / Notices
Desk Officer for the Administration for OMB No.: New Collection. Through the proposed information
Children and Families. Description: The Administration for collection, the researchers will obtain
Children and Families (ACF) at the U.S. information about the characteristics,
Robert Sargis, Department of Health and Human qualifications, and career trajectories of
Reports Clearance Officer. Services (HHS), in collaboration with home visiting staff. The study will
[FR Doc. 2018–03091 Filed 2–13–18; 8:45 am] the Health Resources and Services include a national survey of the
BILLING CODE 4184–45–P Administration (HRSA), seeks approval MIECHV workforce, interviews with
to collect information from home training and technical assistance
visiting program staff in programs
DEPARTMENT OF HEALTH AND experts, and site visits to home visiting
receiving funding through the Maternal,
HUMAN SERVICES programs in eight states that vary in
Infant, and Early Childhood Home
Visiting (MIECHV) Program as part of terms of geography, population
Administration for Children and the Home Visiting Career Trajectories demographics, labor markets, and home
Families study. ACF is interested in collecting visiting program offerings.
Submission for OMB Review; information about the state of the home Respondents: Home visiting program
Comment Request visiting workforce, career trajectories of managers, supervisors, home visitors,
home visitors, and strategies for and training and technical assistance
Title: Home Visiting Career building a pipeline of qualified home experts.
Trajectories. visitors and supervisors.
ANNUAL BURDEN ESTIMATES
Total/annual Number of Average Annual
Instrument number of responses per burden hours burden hours
respondents respondent per response
Home visitor and supervisor survey ................................................................ 3,000 1 0.38 1,140
Program manager survey ................................................................................ 700 1 0.33 231
Focus group moderator’s guide ....................................................................... 480 1 2 960
Self-administered questionnaire for focus group participants ......................... 480 1 0.03 14
Key informant interview guide—management and supervisory staff .............. 80 1 1.5 120
Key informant interview guide—training and technical assistance experts .... 30 1 1.5 45
Estimated Total Annual Burden DEPARTMENT OF HEALTH AND ADDRESSES: You may submit comments
Hours: 2,510. HUMAN SERVICES as follows. Please note that late,
Additional Information: Copies of the untimely filed comments will not be
Food and Drug Administration considered. Electronic comments must
proposed collection may be obtained by
[Docket No. FDA–2014–E–2336] be submitted on or before April 16,
writing to the Administration for
2018. The https://www.regulations.gov
Children and Families, Office of
Determination of Regulatory Review electronic filing system will accept
Planning, Research and Evaluation, 330 comments until midnight Eastern Time
Period for Purposes of Patent
C Street SW, Washington, DC 20201, at the end of April 16, 2018. Comments
Extension; JUVEDERM VOLUMA XC
Attn: OPRE Reports Clearance Officer. received by mail/hand delivery/courier
All requests should be identified by the AGENCY: Food and Drug Administration, (for written/paper submissions) will be
title of the information collection. Email HHS. considered timely if they are
address: OPREinfocollection@ ACTION: Notice. postmarked or the delivery service
acf.hhs.gov. acceptance receipt is on or before that
SUMMARY: The Food and Drug
OMB Comment: OMB is required to date. Furthermore, any interested
Administration (FDA) has determined
make a decision concerning the person may petition FDA for a
the regulatory review period for
collection of information between 30 determination regarding whether the
JUVEDERM VOLUMA XC and is
and 60 days after publication of this applicant for extension acted with due
publishing this notice of that
document in the Federal Register. diligence during the regulatory review
determination as required by law. FDA
Therefore, a comment is best assured of period by August 13, 2018. See
has made the determination because of
having its full effect if OMB receives it the submission of an application to the ‘‘Petitions’’ in the SUPPLEMENTARY
INFORMATION section for more
within 30 days of publication. Written Director of the U.S. Patent and
Trademark Office (USPTO), Department information.
comments and recommendations for the
proposed information collection should of Commerce, for the extension of a Electronic Submissions
be sent directly to the following: Office patent which claims that medical Submit electronic comments in the
of Management and Budget, Paperwork device. following way:
Reduction Project, Email: OIRA_ DATES: Anyone with knowledge that any • Federal eRulemaking Portal:
SUBMISSION@OMB.EOP.GOV, Attn: of the dates as published (in the https://www.regulations.gov. Follow the
daltland on DSKBBV9HB2PROD with NOTICES
Desk Officer for the Administration for SUPPLEMENTARY INFORMATION section) are instructions for submitting comments.
Children and Families. incorrect may submit either electronic Comments submitted electronically,
or written comments and ask for a including attachments, to https://
Mary Jones,
redetermination by April 16, 2018. See www.regulations.gov will be posted to
ACF/OPRE Certifying Officer. ‘‘Petitions’’ in the SUPPLEMENTARY the docket unchanged. Because your
[FR Doc. 2018–03093 Filed 2–13–18; 8:45 am] INFORMATION section for more comment will be made public, you are
BILLING CODE 4184–74–P information. solely responsible for ensuring that your
VerDate Sep<11>2014 22:07 Feb 13, 2018 Jkt 244001 PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 E:\FR\FM\14FEN1.SGM 14FEN1](https://thefederalregister.org/doc/83_FR_6604/page/2.svg)
Document Created: 2018-02-14 03:59:17
Document Modified: 2018-02-14 03:59:17
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| FR Citation | 83 FR 6573 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR